Coronavirus Disease 2019 (COVID-19) | FDA

Coronavirus Disease 2019 (COVID-19) | FDA

FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last MCMi email update on July 22, 2020 include: Coronavirus (COVID-19) Updates: July 28, 2020: Daily Roundup: FDA actions on vaccines, molecular-based diagnostic tests and more July 27, 2020: FDA Reiterates Warning About Dangerous Alcohol-Based Hand Sanitizers Containing Methanol, Takes Additional Action to Address Concerning Products July 24, 2020: FDA Authorizes First Diagnostic Test for Screening of People Without Known or Suspected COVID-19 Infection - Authorization is also second to allow testing of pooled samples July 22, 2020: FDA In Brief: Findings from Real-World Data Study Reveal Higher Risk of Hospitalization and Death Among Cancer Patients with COVID-19, Underscore Health Disparities Also see the features and Emergency Use Authorization Updates below

COVID-19 Updates from FDA